Antibiotics in the combination therapy of bacterial rhinosinusitis: Possibilities and limitations

Nosulia E.V.

doi:https://doi.org/

Nosulia E.V.

Antibiotics in the combination therapy of bacterial rhinosinusitis: Possibilities and limitations

Authors:

Nosulia E.V.

More about the authors

Journal: Russian Rhinology. 2014;22(3): 36‑40

Read: 12596 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nosulia EV. Antibiotics in the combination therapy of bacterial rhinosinusitis: Possibilities and limitations. Russian Rhinology. 2014;22(3):36‑40. (In Russ.)

Подписка 2026 Российская ринология (Russian Rhinology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Antibiotic consumption in dentistry and antibiotic resistance in Russia and the world. Russian Journal of Stomatology. 2025;(2):68-72

Abstract:

The paper gives data on the importance of antibacterial therapy in the combination treatment of acute bacterial sinusitis. In terms of the higher resistance of the likely pathogens of this disease to -lactams and macrolides, the author gives data on the efficacy of respiratory fluoroquinolones, Glevo in particular, in the treatment of bacterial sinusitis.

Keywords:

acute bacterial sinusitis

antibiotics

Authors:

Nosulia E.V.

Close metadata

References:

Bogomil'sky M.R., Strachunsky L.S. Ratsional'naya terapiya ostrykh I khronicheskikh sinusitov u detey. V kn.: Aktual'nye voprosy otorinolaringologii detskogo vozrasta v farmakoterapii bolezney LOR-otganov [The rational treatment of acute and chronic sinusitis in the children. In: The topical problems of pediatric otorhinolaryngology in the context of pharmacotherapy of ENT diseases in the children]. M 2001. [In Russ.].
Strachunsky L.S., Bogomil'sky M.R. Antibakterial'naya terapiya sinusita u detey. V kn.: Aktual'nye voprosy otorinolaringologiidetskogo vozrasta v farmakoterapii bolezney LOR-otganov [Antibacterial therapy of sinusitis in the children. In: The topical problems of pediatric otorhinolaryngology in the context of pharmacotherapy of ENT diseases in the children]. M 2001. [In Russ.].
Piskunov S.Z., Piskunov G.Z., El'kov I.V., et al. Problema obshchego I mestnogo konservativnogo lecheniya ostrogo I khronicheskogo gaimorita [The problem of systemic and local conservative treatment of acute and chronic maxillary sinusitis]. Ros rinol 1994; 5-15. [In Russ.].
Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F., Cohen N., Cervin A., Douglas R., Gevaert P., Georgalas C., Goossens H., Harvey R., Hellings P., Hopkins C., Jones N., Joos G., Kalogjera L., Kern B., Kowalski M., Price D., Riechelmann H., Schlosser R., Senior B., Thomas M., Toskala E., Voegels R., Wang de Y., Wormald P.J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012; 50 (1): 1-12.
Berg О., Carenfelt С. Analysis of symptoms and clinical signs in maxillary sinus empyema. Ada Oto-Laryngol (Stockholm) 1988; 105: 343-349.
Kaiser L., Lew D., Hirschel B. et al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996; 347 (9014): 1507-1510.
Hansen J.G., Schmidt H., Grinsted P. Randomized, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice. Scand J Prim Health Care 2000; 18 (1): 44-47.
Sidorenko S.V., Guchev I.A. Antibakterial'naya terapiya sinusita: sovremenny vzglyad na problem [Anibacterial therapy of sinusitis: the modern view of the problem]. Infektsii I antimikrob ter 2004; 6 (1): 13-16. [In Russ.].
Chow A.W., Benninger M.S., Brook I., Brozek J.L. et al. Klinicheskie rekomendatsii Amerikanskogo obshchestva infektsionistov po lecheniyu ostrogo bakterial'nogo rinosinusita u vzroslykh I detey [The clinical recommendations of the Infectious Diseases Society of America on the treatment of acute bacterial rhinosinusitis in adults and children]. Vestn prakt vracha. Spetsvypusk 2012; 2.
Brook I. Microbiology and antimicrobial management of sinusitis. J Laryngol Otol 2005; 119 (4): 251-258.
Decousser J.W., Allouch P.Y., Courvalin P., Leclercq R. Study Group. In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey. Int J Antimicrob Agents 2002; 20 (3): 186-195.
Anon J.B. Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. Clin Infect Dis 2005; 41 (Suppl. 2): S167-S176.
Hurst M., Lamb H.M., Scott L.J., Figgitt D.P. Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs 2002; 62 (14): 2127-2167.
Van Bambeke F., Tulkens P.M. Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug Saf 2009; 32 (5): 359-378.
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/ANDAGenericDrugApprovals/ucm263853.htm
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm259951.htm; http://www.antibiotic.ru/index.php?article=2111
Nesterova K.I. Respiratornye fitokhinoliny v lechenii khronicheskikh gnoinykh rinosinusitov: kliniko-ekonomicheskaya otsenka [The application of respiratory phytoquinolines for the treatment of chronic suppurative sinusitis: the estimation of the cost-and-benefit ratio]. Ros otorinolaringol 2012; 5: 167-173. [In Russ.].